↓ Skip to main content

Efficacy and Safety of Botulinum Toxin vs. Placebo in Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Overview of attention for article published in Frontiers in Psychiatry, December 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter
16 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
21 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and Safety of Botulinum Toxin vs. Placebo in Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Published in
Frontiers in Psychiatry, December 2020
DOI 10.3389/fpsyt.2020.603087
Pubmed ID
Authors

Huan Qian, Fangjie Shao, Cameron Lenahan, Anwen Shao, Yingjun Li

X Demographics

X Demographics

The data shown below were collected from the profiles of 16 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Lecturer 3 14%
Other 2 10%
Professor 2 10%
Researcher 2 10%
Student > Ph. D. Student 2 10%
Other 2 10%
Unknown 8 38%
Readers by discipline Count As %
Medicine and Dentistry 7 33%
Psychology 2 10%
Nursing and Health Professions 1 5%
Agricultural and Biological Sciences 1 5%
Unknown 10 48%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 August 2022.
All research outputs
#2,949,108
of 25,374,374 outputs
Outputs from Frontiers in Psychiatry
#1,697
of 12,565 outputs
Outputs of similar age
#75,990
of 524,740 outputs
Outputs of similar age from Frontiers in Psychiatry
#82
of 511 outputs
Altmetric has tracked 25,374,374 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,565 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.4. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 524,740 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 511 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.